K. Felder

发表

The health status of women of color.

K. Felder, 1996, Journal of the American Medical Women's Association.

Effects of the new oral angiotensin converting enzyme inhibitor 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) in essential hypertension.

P. Witte, K. Felder, 1984, Arzneimittel-Forschung.